Immunogenicity 14930
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ASGR2
Transcript ID
uc010clw.2
HLA INFO
B*27:02
TCR INFO
No TCR info found!
Full length protein sequence (137 aa)
MAKDF
1
QDIQQ
6
LSSEE
11
NDHPF
16
HQGPP
21
PAQPL
26
AQRLC
31
SMVCF
36
SLLAL
41
SFNIL
46
LLVVI
51
CVTGS
56
QSAQL
61
QAELR
66
SLKEA
71
FSNFS
76
SSTLT
81
EVQAI
86
STHGG
91
SVGDK
96
ITSLG
101
AKLEK
106
QQQDL
111
KAGQR
116
ASGVC
121
AHVRA
126
CVRVR
131
CV
136
Mutation Information
DNA mutation:
None
Peptide Range:
65 ~ 89
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"LQAELRSLKEAFSNFSSSTLTEVQA
||||||||||||.||||||||||||
Mutant:
LQAELRSLKEAFNNFSSSTLTEVQA"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) ASGR2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay